NCT06023199 Assessing Physical Function in Sickle Cell Patients Taking Voxelotor Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05018728 The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell Anemia Status TERMINATED Phase PHASE2
NCT04724421 Expanded Access Protocol for Adults and Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options Status NO_LONGER_AVAILABLE Phase N/A
NCT04335721 A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease Status TERMINATED Phase PHASE1/PHASE2
NCT04247594 Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD Status TERMINATED Phase PHASE2
NCT04218084 Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease Status TERMINATED Phase PHASE3
NCT03943615 Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options Status NO_LONGER_AVAILABLE Phase N/A
NCT03573882 Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031 Status TERMINATED Phase PHASE3
NCT03036813 Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE) Status COMPLETED Phase PHASE3
NCT02850406 Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease Status TERMINATED Phase PHASE2